A step-by-step approach for selecting an optimal minimal important difference

Researchers have proposed that the minimal important difference (MID), the smallest change or difference that patients perceive as important, could aid the interpretation of patient reported outcomes measure (PROM) scores. When multiple MIDs for a given PROM differ substantially, the selection of an optimal MID to aid interpretation could prove challenging. This article describes a systematic, step-by-step selection approach developed to resolve this problem. An optimal MID, at least, should be methodologically sound and should, as far as possible, match the intended application contexts. Therefore, this approach is geared to explaining the variability of the MIDs for the PROM of interest by the methodological rigor and contextualised factors influencing the MID application, and where appropriate, provides one optimal MID (ie, the median of the selected estimates in a relatively narrow range).

[1]  C. Terwee,et al.  An extension MID credibility item addressing construct proximity is a reliable alternative to correlation item. , 2023, Journal of Clinical Epidemiology.

[2]  G. Guyatt,et al.  Serious reporting deficiencies exist in minimal important difference studies: Current state and suggestions for improvement. , 2022, Journal of clinical epidemiology.

[3]  L. Feldman,et al.  Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trials , 2022, The Lancet.

[4]  M. Betsch,et al.  Anterior cruciate ligament patellar tendon autograft fixation at 0 degrees versus 30 degrees results in improved activity scores and a greater proportion of patients achieving the MCID for KOOS Pain - A randomized controlled trial. , 2021, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[5]  G. Guyatt,et al.  A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes. , 2021, Journal of clinical epidemiology.

[6]  C. Terwee,et al.  Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures , 2021, Quality of Life Research.

[7]  K. Wartolowska,et al.  Patient-reported outcome measures (PROMs) as proof of treatment efficacy , 2021, BMJ Evidence-Based Medicine.

[8]  L. Schneider,et al.  The need to show minimum clinically important differences in Alzheimer's disease trials. , 2021, The lancet. Psychiatry.

[9]  G. Guyatt,et al.  Minimal important difference estimates for patient-reported outcomes: A systematic survey. , 2020, Journal of clinical epidemiology.

[10]  J. Manson,et al.  Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. , 2020, JAMA.

[11]  G. Guyatt,et al.  Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study , 2020, BMJ.

[12]  Michael Koller,et al.  International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. , 2020, The Lancet. Oncology.

[13]  J. Malec,et al.  A Standard Method for Determining the Minimal Clinically Important Difference for Rehabilitation Measures. , 2020, Archives of physical medicine and rehabilitation.

[14]  N. Osada,et al.  Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity. , 2019, Acta dermato-venereologica.

[15]  I. Merkies,et al.  The minimum clinically important difference: which direction to take , 2019, European journal of neurology.

[16]  G. Guyatt,et al.  Minimal important differences for improvement in shoulder condition patient-reported outcomes: a systematic review to inform a BMJ Rapid Recommendation , 2019, BMJ Open.

[17]  Lisa V. Hampson,et al.  DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial , 2018, British Medical Journal.

[18]  M. King,et al.  Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR) , 2018, Quality of Life Research.

[19]  D. Beaton,et al.  Minimal Clinically Important Difference: A Review of Outcome Measure Score Interpretation. , 2018, Rheumatic diseases clinics of North America.

[20]  Joanna Coast,et al.  Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension , 2018, JAMA.

[21]  S. Chhatre,et al.  Minimal important difference to infer changes in health-related quality of life-a systematic review. , 2017, Journal of clinical epidemiology.

[22]  G. Guyatt,et al.  Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations , 2017, BMJ Open.

[23]  Deborah Schrag,et al.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  N. Mabvuure,et al.  Minimal important changes and differences in elective hand surgery , 2015, The Journal of hand surgery, European volume.

[25]  A. Gnanasakthy,et al.  Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013). , 2015, Contemporary clinical trials.

[26]  A. Gnanasakthy,et al.  Inclusion of Patient-Reported Outcome Measures In Registered Clinical Trials: Evidence From Clinicaltrials.Gov (2007-2013) , 2015 .

[27]  R. Lewis,et al.  Minimal clinically important difference: defining what really matters to patients. , 2014, JAMA.

[28]  P. Shah,et al.  A practitioner's guide to developing critical appraisal skills: what is the difference between clinical and statistical significance? , 2013, Journal of the American Dental Association.

[29]  R. Lühmann,et al.  A Framework for Managing the Minimal Clinically Important Difference in Clinical Trials , 2013, Therapeutic innovation & regulatory science.

[30]  David Moher,et al.  Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. , 2013, JAMA.

[31]  Nick Black,et al.  Patient reported outcome measures could help transform healthcare , 2013, BMJ.

[32]  Joanne Greenhalgh,et al.  Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations , 2012, Quality of Life Research.

[33]  Alexis Wright,et al.  Clinimetrics corner: a closer look at the minimal clinically important difference (MCID) , 2012, The Journal of manual & manipulative therapy.

[34]  J. Schoones,et al.  Minimal clinically important differences in health-related quality of life after total hip or knee replacement , 2012, Bone & joint research.

[35]  Kristian Thorlund,et al.  Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units , 2010, Health and quality of life outcomes.

[36]  G. Guyatt,et al.  The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature , 2008, Quality of Life Research.

[37]  R. Hays,et al.  Responsiveness and minimal important differences for patient reported outcomes , 2006, Health and quality of life outcomes.

[38]  G. Guyatt,et al.  How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure , 2006, Health and quality of life outcomes.

[39]  G. Guyatt,et al.  Commentary--goodbye M(C)ID! Hello MID, where do you come from? , 2005, Health services research.

[40]  N. Leidy,et al.  Bridging the Gap: Using Triangulation Methodology to Estimate Minimal Clinically Important Differences (MCIDs) , 2005, COPD.

[41]  G. Guyatt,et al.  A critical look at transition ratings. , 2002, Journal of clinical epidemiology.

[42]  Gordon H Guyatt,et al.  Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.

[43]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[44]  G. Guyatt,et al.  The minimal detectable change cannot reliably replace the minimal important difference. , 2010, Journal of clinical epidemiology.

[45]  Author manuscript, published in "Journal of Clinical Epidemiology 2009;62(7):725-8" DOI: 10.1016/j.jclinepi.2008.09.012 The variability in Minimal Clinically Important Difference and Patient Acceptable Symptomatic State values did not impact on treatment , 2009 .

[46]  COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) , 2008 .